CSIRO HELPS DEVELOP AUSTRALIAN PHARMA COMPANY FROM $10 MILLION TO $305 MILLION
23 March 2017, Written by Mia Armitage
GOVERNMENT backed scientists have helped multiply the market value of a previously small Australian pharmaceutical company by 30 in seven years.
MVP shares are trading at $5.20 per share at 10am AEDT today.
Business News Australia
Author: Mia Armitage Connect via: Twitter